Observed Signal · Sep 8, 2026 · Funding · Source: Tech.eu (European Tech & Deals) · Impact: 3/5 · Sentiment: Positive
sci2sci raises €1.2M for AI verification in regulated industries
Berlin-based startup sci2sci has secured €1.2 million in pre-seed funding to advance its technology for organizing and verifying data in regulated industries like biopharma and banking. The round was co-led by Heliad and IBB Ventures, with participation from Robin Capital and Superangels. The company develops a neurosymbolic memory layer that transforms scattered corporate data into self-verifying knowledge. Its flagship product, Integrity Cortex, encodes information as a formal logic system where every claim must cite a literal source, and a symbolic engine verifies citations, flagging hallucinations and inconsistencies. This provides an auditable record compliant with 21 CFR Part 11. VectorCat serves as a data integration layer, connecting information across cloud and laboratory systems. Senior advisor Stephanie Bova, former Corporate VP at Novo Nordisk, has joined sci2sci. The funding will expand the engineering team, deepen customer deployments, and extend products into banking.
Funding for AI infrastructure in regulated industries is relevant to AdTech's data verification and AI-driven processes.
Track Real-Time Funding Signals & Market Shifts
Polaris7 autonomous intelligence agents track regulatory filings, primary sources, executive changes, and deal flow 24/7. Create your free Explorer workspace to monitor these entities.
Key Takeaways & Evidence Grounding
- sci2sci raised €1.2 million in pre-seed funding, co-led by Heliad and IBB Ventures, with participation from Robin Capital and Superangels.
- The flagship product Integrity Cortex uses a formal logic system to verify citations and ensure compliance with 21 CFR Part 11.
- VectorCat serves as a data integration layer connecting information across systems.
- Stephanie Bova, former Corporate VP at Novo Nordisk, joined sci2sci as a senior advisor.
- Funding will be used to expand the engineering team, deepen deployments, and extend into banking.
Ontology Mapping & Concepts
Related Market Signals & Shifts
Recent verified developments and strategic activity across this market segment.
Biolevate raises €30M Series A for life sciences AI
Biolevate, a Paris-based life sciences AI company, has raised €30 million in Series A funding to scale its enterprise agentic AI platform designed to automate scientific and regulatory workflows. The round was co-led by RAISE France and Orange Ventures, with participation from MSD Global Health Innovation Fund, Station F, and existing investor EQT Ventures. The platform enables life sciences organizations to run thousands of concurrent AI agents, with outputs grounded in source evidence and human oversight, facilitating use in regulated environments. Since its 2024 seed round, Biolevate has expanded to over a dozen enterprise customers, achieving significant efficiency gains in literature reviews and regulatory intelligence. The company is opening a US office in Boston, has doubled headcount, and plans to double again, while also filing patents in Europe.
UK startup Pharosyn raises €2.5 million for pharma competitive intelligence platform
London-based Pharosyn, an AI-powered competitive intelligence platform for biopharma, has raised €2.5 million in a funding round led by Moonfire, with participation from Entrepreneurs First, Transpose Platform, and General Advance. The company plans to expand its platform and support wider adoption across pharmaceutical commercial and portfolio strategy teams. Founded in 2025 by Stephen Cowley and Joshua Hampson, Pharosyn monitors clinical, regulatory, and commercial data sources to produce strategic reports tailored to an organisation's pipeline. The funding is part of a broader trend of AI investment in pharma, with EU-Startups reporting approximately €75.3 million across seven comparable rounds this year.
Vienna RegTech Signteq Secures Seven-Figure Investment from Peter Steinberger
Viennese RegTech startup signteq has closed a seven-figure funding round, with notable new investor Peter Steinberger (creator of OpenClaw and OpenAI employee), alongside Runtastic co-founder René Giretzlehner and Franz-Mayr-Melnhof-Saurau Beteiligungs GmbH. Existing investor Compass-Verlag, a shareholder since 2024, increased its stake. Founded in 2019 and led by Simon Schnabl, the company offers a platform for digital identity verification, KYC/KYB checks, PEP and sanctions screening, and qualified electronic signatures, serving banks, fintechs, and the public sector. The funds will fuel international expansion into Germany and Switzerland and support the development of 'Know Your Agent' (KYA), a new business line for verifying AI agent identity and authorization. Signteq also plans to integrate the EUDI Wallet into its platform, capitalizing on upcoming regulations like eIDAS 2.0 and the EU's Anti-Money Laundering Regulation.
Track Real-Time Market Signals & Shifts
Set up custom watchlists to receive automated, evidence-grounded executive digests whenever material signals or shifts occur across your tracked landscape.